Reality Sandwiches

Delic Labs to Present on Psychedelics, Cannabis Extraction at Grow Up Conference and Expo

Retrieved on: 
Thursday, June 16, 2022
Metabolomics, Time, Intellectual property, Industry, Education, Reality Sandwiches, COVID-19, Phrase, Person, Compliance, University, Company, Health Canada, Research, Private Securities Litigation Reform Act, Growth, Psilocybin, LSD, Tripura Merger Agreement, MDMA, Failure, Health, Cannabis, Nature, Transaction, UBC, Legislation, Patient, IP, DMT, Mescaline, Multimedia, Mergers and acquisitions, Conference, Therapy, Regulation, Video game, Risk management

Securing a Dealer's License to accompany its existing research exemptions would cement Delic Labs' position as the leader in psychedelic safety testing.

Key Points: 
  • Securing a Dealer's License to accompany its existing research exemptions would cement Delic Labs' position as the leader in psychedelic safety testing.
  • The Company aims to establish consistent quality control standards as more patients and clinicians incorporate psychedelic compounds into treatment plans.
  • Delic Labs is a federally licensed cannabis and psilocybin research laboratory focused on extraction optimization, analytical testing, and process development.
  • In addition, in connection with the forward-looking information and forward-looking statements contained in this press release, Delic has made certain assumptions.

DELIC HOLDINGS CORP ANNOUNCES FILING OF ANNUAL DOCUMENTS

Retrieved on: 
Tuesday, May 31, 2022
Education, Company, News, Multimedia, Mission statement, View, Research, Reality Sandwiches, CSE, Industry, Canadian Securities Exchange, Forward-looking statement, Annual Filing Season Program, Delić, Health Canada, FRA, DELC, Audit, BC

While the MCTO remains in effect, the general investing public will continue to be able to trade the Company's securities.

Key Points: 
  • While the MCTO remains in effect, the general investing public will continue to be able to trade the Company's securities.
  • Delic is a leader in new medicines and treatments for a modern world, improving access to health benefits across the country and reframing the conversation on psychedelics.
  • This news release contains certain forward-looking information and forward-looking statements within the meaning of applicable Canadian and United States securities legislation (collectively "forward-looking statements").
  • For more information on the Company, its subsidiaries and the risks and challenges of their businesses, investors should review their annual filings that are available at www.sedar.com .

Delic Corp to Present on Company's Expansion Strategy, Industry Outlook at H.C. Wainwright Conference

Retrieved on: 
Wednesday, May 18, 2022
Education, Company, News, Multimedia, View, EST, Research, Magic City, Reality Sandwiches, CSE, Industry, Conference, Forward-looking statement, Delić, Health Canada, FRA, DELC, CEO, Pharmaceutical industry, BC

Hosted in the Magic City, the H.C. Wainwright Annual Global Life Sciences Conference is a four-day event consisting of keynote presentations, investor one-on-one meetings, networking opportunities and evening entertainment.

Key Points: 
  • Hosted in the Magic City, the H.C. Wainwright Annual Global Life Sciences Conference is a four-day event consisting of keynote presentations, investor one-on-one meetings, networking opportunities and evening entertainment.
  • At this year's conference, Stang will participate in one-on-one meetings and present the Company's expansion strategy.
  • For those unable to attend this year's conference, his presentation will be available beginning June 10 at 7 a.m. EST.
  • Delic is a leader in new medicines and treatments for a modern world, improving access to health benefits across the country and reframing the conversation on psychedelics.

DELIC HOLDINGS CORP PROVIDES DEFAULT STATUS UPDATE

Retrieved on: 
Monday, May 16, 2022
Education, SEC filing, Company, NP, News, Multimedia, Mission statement, View, Default, Research, Reality Sandwiches, National, CSE, Industry, Canadian Securities Exchange, Forward-looking statement, Annual Filing Season Program, Delić, Health Canada, FRA, DELC, Lease, BC

VANCOUVER, BC, May 16, 2022 /PRNewswire/ - Delic Holdings Corp ("DELIC" or the "Company") (CSE: DELC ) (OTCQB: DELCF ) (FRA: 6X0 ), a leader in new medicines and treatments for a modern world, is providing a default status report in accordance with the alternative information guidelines set out in National Policy 12-203 - Management Cease Trade Orders ("NP 12-203").

Key Points: 
  • VANCOUVER, BC, May 16, 2022 /PRNewswire/ - Delic Holdings Corp ("DELIC" or the "Company") (CSE: DELC ) (OTCQB: DELCF ) (FRA: 6X0 ), a leader in new medicines and treatments for a modern world, is providing a default status report in accordance with the alternative information guidelines set out in National Policy 12-203 - Management Cease Trade Orders ("NP 12-203").
  • The Company confirms it will continue to satisfy the provisions of the alternative information guidelines set out in NP 12-203 so long as it remains in default of the requirement to file the Annual Filings.
  • Delic is a leader in new medicines and treatments for a modern world, improving access to health benefits across the country and reframing the conversation on psychedelics.
  • This news release contains certain forward-looking information and forward-looking statements within the meaning of applicable Canadian and United States securities legislation (collectively "forward-looking statements").

Ketamine Wellness Centers Announces Partnership With The Veterans Administration (VA) in Arizona

Retrieved on: 
Thursday, May 12, 2022
Physician, Risk, Education, Suicide, COO, Veteran, Anxiety, Patient, Multimedia, Tuskegee Veterans Administration Medical Center, Contract, View, Insurance, IV, Health Promotion International, Ketamine, Research, Reality Sandwiches, CSE, Industry, PTSD, OCD, United States Department of Veterans Affairs, Fortis Healthcare, Partnership, KWC, United States Public Health Service, Chronic pain, Queensland Community Care Network, Health Canada, Depression, FRA, DELC, CEO, Pharmaceutical industry, Health insurance, Online shopping

More than 20 million veterans live in the United States and the state of Arizona is home to upwards of 500,000 veterans.

Key Points: 
  • More than 20 million veterans live in the United States and the state of Arizona is home to upwards of 500,000 veterans.
  • In addition to the VA partnership, KWC also partnered with the Veterans Administration (VA) Community Care Network last year to offer ketamine treatments to veterans at no out-of-pocket cost at their locations in Burnsville and Naperville, Illinois.
  • For more information about Ketamine Wellness Centers' locations, services and hours of operation, please visit https://www.ketaminewellnesscenters.com/locations/ .
  • Ketamine Wellness Centers (KWC) is the largest ketamine therapy provider in the United States with 13 clinic locations serving communities across nine states.

IBN (InvestorBrandNetwork) Announces Success Story Podcast Interview with Delic Holdings Corp Co-Founder and CEO Matt Stang

Retrieved on: 
Thursday, May 5, 2022
Criminalization, Ecosystem, Reality Sandwiches, High Times, IBN, Terror, Q&A, Cannabis, GLOBE, Securities Exchange Act of 1934, Securities Act of 1933, Time, CSE, Entrepreneurship, Review, Success, Freedom, FRA, Delić, Industry, Knowledge, History, Marketing, Science, Education, Health Canada, SEC, Life, Solution, News, CEO, Research, Interview, DELC, Social media, High, Management, Drug, Public relations

The broadcast, hosted by entrepreneur, business executive, author, educator and speaker Scott D. Clary, is available for on-demand viewing on The Success Story Podcast .

Key Points: 
  • The broadcast, hosted by entrepreneur, business executive, author, educator and speaker Scott D. Clary, is available for on-demand viewing on The Success Story Podcast .
  • During the interview, Stang discussed his background in cannabis before explaining his decision to move into psychedelics and co-found Delic.
  • I was an owner and operator of a company called High Times for about 17 years before selling it to a private equity group, Stang said.
  • It began with me writing a senior thesis in college about marijuana legalization in the time of terror, because it was 2001.

Ketamine Wellness Centers (KWC) Introduces NAD+ Infusion Therapy

Retrieved on: 
Wednesday, May 4, 2022
Reality Sandwiches, Brain, Physician, Depression, NAD, Patient, Immunity, CSE, FRA, Delić, Ketamine, Industry, Anxiety, DNA, Signal, Veteran, Method, PTSD, Education, View, Health Canada, Chronic pain, IV, Mental health, OCD, CEO, KWC, Research, DELC, Cell, Multimedia, Pharmaceutical industry, Online shopping

"The introduction of NAD+ infusion therapy to our clinics is a strong complement to ketamine therapy and has benefits for their mental and physical well-being.

Key Points: 
  • "The introduction of NAD+ infusion therapy to our clinics is a strong complement to ketamine therapy and has benefits for their mental and physical well-being.
  • For more information about Ketamine Wellness Centers' locations, services and hours of operation, please visit https://www.ketaminewellnesscenters.com/locations /.
  • Ketamine Wellness Centers (KWC) is the largest ketamine therapy provider in the United States with 13 clinic locations serving communities across nine states.
  • Since 2011 KWC has been a trusted leader in bringing IV ketamine therapy into mainstream health care.

Delic Corp to Participate at Sequire Cannabis and Psychedelic Conference and Scottsdale Capital Event

Retrieved on: 
Tuesday, April 19, 2022
CSE, News, CEO, FRA, Transaction, Phrase, Mergers and acquisitions, COVID-19, Legislation, Research, DELC, Regulation, Compliance, Private Securities Litigation Reform Act, Education, Growth, Conference, Person, Failure, Company, Reality Sandwiches, Cannabis, Canadian Securities Exchange, Health Canada, Tripura Merger Agreement, Industry, Multimedia, Health, Time, Nature, Online shopping, Risk management, Security (finance), CBD, BC

Matt Stang, Co-founder and CEO of Delic Corp, will present on the Company's strategic outlook for the remainder of the year at the Sequire Cannabis and Psychedelic Conference on April 20, 2022, and the Scottsdale Capital Event on April 22-24, 2022.

Key Points: 
  • Matt Stang, Co-founder and CEO of Delic Corp, will present on the Company's strategic outlook for the remainder of the year at the Sequire Cannabis and Psychedelic Conference on April 20, 2022, and the Scottsdale Capital Event on April 22-24, 2022.
  • VANCOUVER, BC, April 19, 2022 /PRNewswire/ - Delic Holdings Corp ("Delic" or the "Company") (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0), a leader in new medicines and treatments for a modern world, today shared details regarding Matt Stang, Co-founder and CEO of Delic, and his participation at the Sequire Cannabis and Psychedelic Conference and the Scottsdale Capital Event.
  • Hosted by Sequire, the virtual event will bring together over 50 leading public companies in the cannabis, CBD, and psychedelic space to discuss the future of their respective industries.
  • Located in Scottsdale, Arizona, the three-day conference includes scheduled meetings and networking events with growing companies and financiers.

Delic Labs Receives Health Canada 56 Exemption to Conduct Research on MDMA, LSD and Other Psychedelic Compounds

Retrieved on: 
Wednesday, April 13, 2022
CSE, News, FRA, Metabolomics, Transaction, Phrase, Mergers and acquisitions, COVID-19, Legislation, Research, Research exemption, DELC, Mescaline, Regulation, Compliance, Private Securities Litigation Reform Act, LSD, Education, Patient, DMT, University, Intellectual property, Growth, Person, Psilocybin, Failure, Company, License, UBC, Reality Sandwiches, Cannabis, Canadian Securities Exchange, Health Canada, IP, Tripura Merger Agreement, Industry, Multimedia, Health, Therapy, Time, MDMA, Nature, Fine chemical, Pharmaceutical industry, Drug, Risk management, BC

Additionally, Delic Labs has received a Health Canada 56 exemption to acquire 60 grams of psilocybin mushrooms from Nectar Health Sciences Laboratory Division Inc., a wholly-owned subsidiary of Psilobrain Therapeutics Inc. Delic Labs' latest exemptions enable the Company to develop innovative analytical methods for psychedelic research.

Key Points: 
  • Additionally, Delic Labs has received a Health Canada 56 exemption to acquire 60 grams of psilocybin mushrooms from Nectar Health Sciences Laboratory Division Inc., a wholly-owned subsidiary of Psilobrain Therapeutics Inc. Delic Labs' latest exemptions enable the Company to develop innovative analytical methods for psychedelic research.
  • Securing a Dealer's License to accompany its existing research exemptions would cement Delic Labs' position as the leader in psychedelic safety testing.
  • Delic Labs is the engine of innovation for Delic Corp, conducting research and developing new product lines and IP.
  • "Securing our latest Health Canada 56 exemptions allow us to advance our research efforts as we continue to understand the medical applications of psychedelic compounds," said Dr. Markus Roggen, co-founder of Delic Labs.

Delic Expansion Accelerating into 2022 with New Clinic Openings

Retrieved on: 
Thursday, March 31, 2022
EBITDA, Method, Therapy, Armenian American Wellness Center, PTSD, Research, CEO, Regulation, Company, Education, Reality Sandwiches, CSE, DMT, MDD, Risk, Lists of diseases, Ketamine, Health, Open Location Code, Grammatical mood, View, Industry, TRD, Person, Tax, Suicidal ideation, Chemistry, Phrase, The Harris Poll, MDMA, Health Canada, Mescaline, IFRS, Growth, Multimedia, Legislation, FRA, Failure, Way, LSD, DELC, Black–Scholes model, Psilocybin, FDA, Patient, IP, Depression, Compliance, KWC, Private Securities Litigation Reform Act, COVID-19, Canadian Securities Exchange, News, Anxiety, Nature, Meat, Online gambling, Pharmaceutical industry, Hospital, Security (finance), Risk management, Bookkeeping, BC

The most recent clinic openings include KWC Salt Lake City on January 10 and KWC Reno on March 7.

Key Points: 
  • The most recent clinic openings include KWC Salt Lake City on January 10 and KWC Reno on March 7.
  • *
    Delic continued to accelerate its expansion plans through the opening of two new Ketamine Wellness Centers (KWC) in the first quarter of 2022.
  • KWC Salt Lake City officially opened its doors on January 10 making it the first KWC clinic in Utah.
  • Last October, Delic Labs also applied for a Dealer's License to commercialize its psilocybin research and associated IP for medical and research purposes.